Walgreens Boots Alliance, Inc. Stock BOERSE MUENCHEN

Equities

W8A

US9314271084

Drug Retailers

Market Closed - BOERSE MUENCHEN 03:53:54 2024-06-28 pm EDT 5-day change 1st Jan Change
11.28 EUR -1.42% Intraday chart for Walgreens Boots Alliance, Inc. -24.29% -53.06%
Sales 2024 * 145B 136B Sales 2025 * 149B 139B Capitalization 10.44B 9.75B
Net income 2024 * -7.92B -7.4B Net income 2025 * 1.42B 1.33B EV / Sales 2024 * 0.13 x
Net Debt 2024 * 8.21B 7.66B Net Debt 2025 * 6.94B 6.48B EV / Sales 2025 * 0.12 x
P/E ratio 2024 *
-1.5 x
P/E ratio 2025 *
7.99 x
Employees -
Yield 2024 *
10.5%
Yield 2025 *
7.97%
Free-Float 60.75%
More Fundamentals * Assessed data
Dynamic Chart
Boots CEO James quits after Walgreens' plans for sale stalls, Sky News reporter says RE
Walgreens' Q3 Earnings Miss Reflects Weak Consumer Spending, Pharmacy Headwinds, Morgan Stanley Says MT
Walgreens' Earnings Guidance Cut Implies 'Notably Weaker' Fourth Quarter, Morgan Stanley Says MT
Walgreens Boots Alliance's Fiscal Q3 Results Reflect Pharmacy Headwinds, Challenging Retail Environment, Truist Securities Says MT
BofA Securities Slashes Price Target on Walgreens Boots Alliance to $11 From $22, Maintains Underperform Rating MT
Truist Cuts Price Target on Walgreens Boots Alliance to $13 From $20, Calls Fiscal Q3 'Difficult,' Keeps Hold Rating MT
Mizuho Adjusts Price Target on Walgreens Boots Alliance to $15 From $19, Maintains Neutral Rating MT
Morgan Stanley Lowers Price Target on Walgreens Boots Alliance to $9 From $13 Amid Guidance Cut, Keeps Underweight Rating MT
Barclays Adjusts Price Target on Walgreens Boots Alliance to $11 From $15, Maintains Underweight Rating MT
Deutsche Bank Adjusts Price Target on Walgreens Boots Alliance to $13 From $22, Maintains Hold Rating MT
Wall St. subdued ahead of debate, inflation data RE
Equities Rise as Markets Analyze Fed Official's Remarks, Macro Data MT
Equities Rise Amid Fed Official's Rate Remarks, Macro Data MT
US Equities Markets Close Higher Thursday as Investors Review Economic Data, Fed Official's Remarks MT
Sector Update: Health Care Stocks Slipping Late Afternoon MT
More news

Latest transcript on Walgreens Boots Alliance, Inc.

1 week-24.29%
Current month-24.96%
1 month-20.59%
3 months-44.16%
6 months-53.21%
Current year-53.06%
More quotes
1 week
10.91
Extreme 10.908
15.15
1 month
10.91
Extreme 10.908
15.18
3 years
10.91
Extreme 10.908
49.89
5 years
10.91
Extreme 10.908
57.89
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 23-10-22
Director of Finance/CFO 45 16-01-31
Chairman 83 12-07-31
Members of the board TitleAgeSince
Director/Board Member 57 22-10-26
Director/Board Member 67 20-10-28
Director/Board Member 68 10-03-31
More insiders
Date Price Change
24-06-28 11.28 -1.42%
24-06-27 11.44 -21.99%
24-06-26 14.66 -0.19%
24-06-25 14.69 -1.73%
24-06-24 14.95 +0.36%

Real-time BOERSE MUENCHEN, June 28, 2024 at 03:53 pm EDT

More quotes
Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
12.1 USD
Average target price
17.08 USD
Spread / Average Target
+41.24%
Consensus